These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1413995)

  • 1. Baculovirus expression of the glycoprotein gene of Lassa virus and characterization of the recombinant protein.
    Hummel KB; Martin ML; Auperin DD
    Virus Res; 1992 Sep; 25(1-2):79-90. PubMed ID: 1413995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection.
    Barber GN; Clegg JC; Lloyd G
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays.
    Hummel KB; Erdman DD; Heath J; Bellini WJ
    J Clin Microbiol; 1992 Nov; 30(11):2874-80. PubMed ID: 1452657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus.
    Morrison HG; Goldsmith CS; Regnery HL; Auperin DD
    Virus Res; 1991 Mar; 18(2-3):231-41. PubMed ID: 2042398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
    Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
    Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection.
    Auperin DD; Esposito JJ; Lange JV; Bauer SP; Knight J; Sasso DR; McCormick JB
    Virus Res; 1988 Feb; 9(2-3):233-48. PubMed ID: 3354260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.
    Ter Meulen J; Koulemou K; Wittekindt T; Windisch K; Strigl S; Conde S; Schmitz H
    J Clin Microbiol; 1998 Nov; 36(11):3143-8. PubMed ID: 9774554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene.
    Fisher-Hoch SP; McCormick JB; Auperin D; Brown BG; Castor M; Perez G; Ruo S; Conaty A; Brammer L; Bauer S
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):317-21. PubMed ID: 2911575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
    Boisen ML; Hartnett JN; Shaffer JG; Goba A; Momoh M; Sandi JD; Fullah M; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Koval AP; Cross RW; Barnes KG; Lachenauer AE; Lin AE; Nekoui M; Kotliar D; Winnicki SM; Siddle KJ; Gbakie M; Fonnie M; Koroma VJ; Kanneh L; Kulakosky PC; Hastie KM; Wilson RB; Andersen KG; Folarin OO; Happi CT; Sabeti PC; Geisbert TW; Saphire EO; Khan SH; Grant DS; Schieffelin JS; Branco LM; Garry RF
    Sci Rep; 2018 Apr; 8(1):5939. PubMed ID: 29651117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.
    ter Meulen J; Badusche M; Kuhnt K; Doetze A; Satoguina J; Marti T; Loeliger C; Koulemou K; Koivogui L; Schmitz H; Fleischer B; Hoerauf A
    J Virol; 2000 Mar; 74(5):2186-92. PubMed ID: 10666248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regions.
    Günther S; Kühle O; Rehder D; Odaibo GN; Olaleye DO; Emmerich P; ter Meulen J; Schmitz H
    Med Microbiol Immunol; 2001 Sep; 189(4):225-9. PubMed ID: 11599793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
    Robinson JE; Hastie KM; Cross RW; Yenni RE; Elliott DH; Rouelle JA; Kannadka CB; Smira AA; Garry CE; Bradley BT; Yu H; Shaffer JG; Boisen ML; Hartnett JN; Zandonatti MA; Rowland MM; Heinrich ML; Martínez-Sobrido L; Cheng B; de la Torre JC; Andersen KG; Goba A; Momoh M; Fullah M; Gbakie M; Kanneh L; Koroma VJ; Fonnie R; Jalloh SC; Kargbo B; Vandi MA; Gbetuwa M; Ikponmwosa O; Asogun DA; Okokhere PO; Follarin OA; Schieffelin JS; Pitts KR; Geisbert JB; Kulakoski PC; Wilson RB; Happi CT; Sabeti PC; Gevao SM; Khan SH; Grant DS; Geisbert TW; Saphire EO; Branco LM; Garry RF
    Nat Commun; 2016 May; 7():11544. PubMed ID: 27161536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenic and protective characteristics of recombinant Lassa virus NP protein].
    Ignat'ev GM
    Vopr Virusol; 2002; 47(2):28-31. PubMed ID: 12046464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rabies virus glycoprotein expressed by recombinant baculovirus.
    Tuchiya K; Matsuura Y; Kawai A; Ishihama A; Ueda S
    Virus Res; 1992 Sep; 25(1-2):1-13. PubMed ID: 1413990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.
    Ruo SL; Mitchell SW; Kiley MP; Roumillat LF; Fisher-Hoch SP; McCormick JB
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():549-55. PubMed ID: 1706408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.
    Seppänen H; Huhtala ML; Vaheri A; Summers MD; Oker-Blom C
    J Clin Microbiol; 1991 Sep; 29(9):1877-82. PubMed ID: 1774311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature dependent characteristics of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells.
    Cain KD; Byrne KM; Brassfield AL; LaPatra SE; Ristow SS
    Dis Aquat Organ; 1999 Apr; 36(1):1-10. PubMed ID: 10349547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.